Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,345,000
-51,000 (-3.65%)
Jul 20, 2026, 3:30 PM KST
Samsung Biologics Stock Forecast
Stock Price Forecast
According to 24 analysts polled by S&P Global, Samsung Biologics stock has a consensus rating of "Strong Buy" and an average price target of ₩2,052,159. The average 1-year stock price forecast is 52.58% higher than the current stock price, while the lowest is ₩1,600,000 (+18.96%) and the highest is ₩2,613,811 (+94.34%).
Price Target: ₩2,052,159 (+52.58%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Samsung Biologics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 15 | 14 | 13 | 14 |
| Buy | 10 | 9 | 9 | 10 | 10 | 10 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 26 | 25 | 24 | 24 | 23 | 24 |
Financial Forecast
Revenue This Year
5.38T
from 4.56T
Increased by 18.01%
Revenue Next Year
6.29T
from 5.38T
Increased by 16.92%
EPS This Year
42.40K
from 26.63K
Increased by 59.25%
EPS Next Year
49.13K
from 42.40K
Increased by 15.86%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.